CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing by Labun, Kornel et al.
Published online 20 May 2019 Nucleic Acids Research, 2019, Vol. 47, Web Server issue W171–W174
doi: 10.1093/nar/gkz365
CHOPCHOP v3: expanding the CRISPR web toolbox
beyond genome editing
Kornel Labun 1, Tessa G. Montague2, Maximilian Krause1, Yamila N. Torres Cleuren1,
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ABSTRACT
The CRISPR–Cas system is a powerful genome edit-
ing tool that functions in a diverse array of organ-
isms and cell types. The technology was initially de-
veloped to induce targeted mutations in DNA, but
CRISPR–Cas has now been adapted to target nu-
cleic acids for a range of purposes. CHOPCHOP is
a web tool for identifying CRISPR–Cas single guide
RNA (sgRNA) targets. In this major update of CHOP-
CHOP, we expand our toolbox beyond knockouts.
We introduce functionality for targeting RNA with
Cas13, which includes support for alternative tran-
script isoforms and RNA accessibility predictions.
We incorporate new DNA targeting modes, includ-
ing CRISPR activation/repression, targeted enrich-
ment of loci for long-read sequencing, and predic-
tion of Cas9 repair outcomes. Finally, we expand
our results page visualization to reveal alternative
isoforms and downstream ATG sites, which will aid
users in avoiding the expression of truncated pro-
teins. The CHOPCHOP web tool now supports over
200 genomes and we have released a command-line
script for running larger jobs and handling unsup-
ported genomes. CHOPCHOP v3 can be found at
https://chopchop.cbu.uib.no
INTRODUCTION
The use of CRISPR–Cas is now ubiquitous in modern
molecular biology. First introduced as a tool for introduc-
ing repair-induced mutations in the genome, the emergence
of catalytically dead or fused versions of the effector pro-
teins has transformed CRISPR–Cas into a general purpose
tool for targeting. For instance, CRISPR–Cas has been used
to introduce new sequences into the genome (1–3), activate
(4,5) or repress (6) transcription, as an enrichment tool for
sequencing (7,8), for targeted hypermutation (9), as a diag-
nostic tool (10), to perform whole-organism lineage tracing
(11), to target RNA molecules for destruction (12) or edit-
ing (13), and to track transcripts in live cells (14).
All CRISPR–Cas applications use a sgRNA to direct
the CRISPR effector (Cas) protein to its target. In theory,
CRISPR–Cas targeting only requires complementarity be-
tween the sgRNA and its nucleic acid target, but a num-
ber of studies have shown that efficient targeting follows
more complex rules (15–21). For instance, the position of
specific nucleotides in the target sequence, the accessibility
of the target site, and the sequence of its flanking regions
can all influence efficiency. The targeting efficiencies of Cas9
and Cas12a/Cpf1 have been measured in large-scale stud-
ies and combined with machine learning-based methods to
optimize cutting (15,21).
There are other factors that can influence or prevent the
generation of a null mutant. For instance, introducing a
frameshift mutation too close to the start codon can per-
mit translation initiation at a downstream ATG, leading to
unintentional protein production. In other cases, targeting
exons that are only present in a subset of isoforms can pre-
vent null mutation generation. Finally, CRISPR–Cas gene
editing can produce confounding phenotypes due to tran-
scription adaptation or genetic compensation. For instance,
a recent study showed that degradation of mutant mRNAs
could result in the upregulation of related genes (22). In
these situations, deleting the promoter can be a more robust
method to produce knockouts.
Many CRISPR–Cas applications require the generation
of a frameshift mutation to disrupt gene function, which re-
quires a DNA repair event in which the number of inserted
or deleted nucleotides is not a multiple of three. Surpris-
ingly, it has been shown that double-strand break (DSB) re-
pairs are not random: Cas9-induced DSBs using the same
sgRNA often give rise to the same mutations (23). Recently,
this has been incorporated into models that predict whether
DSB repairs will give rise to a frameshifting mutation (24).
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In summary, the CRISPR–Cas system has been adapted
for a wide selection of uses, and numerous factors influence
each of these modes, necessitating the existence of intuitive
software for target selection. This new update of the CHOP-
CHOP web tool incorporates new CRISPR–Cas targeting
modes and predicts frameshift mutation frequency in an im-
proved, user-friendly interface.
IMPROVEMENTS IN THE NEW RELEASE
Like previous versions, CHOPCHOP handles input from (i)
gene and transcript identifiers, (ii) genomic coordinates and
(iii) pasted sequences, and provides results in a number of
output formats. The interface is simple (Figure 1) and re-
quires the user to make four selections in the default mode:
(a) target gene/isoform/region, (b) organism, (c) CRISPR
effector (e.g. Cas9, CasX or Cas13), and (d) purpose (e.g.
knockout, knockdown, repression). Advanced users can ad-
just the default settings by clicking the ‘Options’ button
(Figure 1).
While CHOPCHOP queries typically run within a few
seconds, heavy traffic can cause congestion during peak
hours. We have therefore introduced a queuing system that
ensures all users are prioritized. The new system retains re-
sults and calculations for up to 48 h after the initial query,
permitting quick access (via caching) if an identical search
is made later on and sharing results with collaborators. To
increase speed for larger queries, CHOPCHOP also sup-
ports pre-filtering of sgRNA targets by (i) GC content
(with a default of 10–90%) and (ii) the existence of self-
complementarity within the sgRNA. This can greatly re-
duce computation time.
Several adjustments have been made to improve the re-
sults page visualizations. Notably, in-frame downstream
ATGs are now colored in the isoform visualization (Figure
1) to help users avoid downstream translation initiation. In
addition, the results table can now be sorted using any cri-
teria.
In addition to these improvements, the latest CHOP-
CHOP introduces the following new major features.
Targeting the transcriptome
The most widespread use of CRISPR–Cas is to intro-
duce mutations into DNA. However, CRISPR–Cas systems
have now been engineered to target RNA. For instance,
CRISPR–Cas13 has been harnessed for transcript knock-
down (25), live-cell transcript imaging (14) and RNA base
editing (13).
CHOPCHOP now permits CRISPR–Cas13 targeting,
and implements this functionality by searching for off-
targets across the complete transcriptome rather than the
genome. An important aspect of RNA targeting is to avoid
regions of high structure that can reduce the accessibility
of Cas13 (12,14,26). CHOPCHOP calculates RNA acces-
sibility using RNAfold from the ViennaRNA package (27)
according to published recommendations (14). Briefly, ac-
cessibility is calculated in windows of 70 nucleotides, ob-
taining the probability that a given nucleotide position in
the transcript is unpaired. For each target, we take the mean
probability of structure across each position targeted by the
sgRNA (14).
Similar to protospacer adjacent motifs (PAMs) in DNA-
targeting modes, we support any 5′ or 3′ protospacer flank-
ing sequences (PFS) for RNA targeting. The Cas13a PFS
- an H at the 3′ end of the target - is the default. As with
the PAM, the PFS should be present in the sequence of the
DNA or RNA target, but not in the sgRNA. CHOPCHOP
provides the appropriate sgRNA sequence, ensuring that
the user does not include the PFS when ordering the sgRNA
oligonucleotide.
New modes for targeting the genome
CHOPCHOP v3 expands the number of modes for DNA
targeting. These include: (i) Nanopore enrichment mode.
Targeted sequencing is a method used to attain high quality
sequencing reads in a specific region of interest. PCR-based
methods for enriching genomic regions have some limita-
tions, for instance the maximum length of the region that
can be enriched. By contrast, CRISPR–Cas provides a pow-
erful method to excise genomic regions prior to amplifica-
tion and sequencing with Oxford Nanopore Technologies
(ONT) (7,8). The nanopore enrichment mode in CHOP-
CHOP allows users to identify pairs of gRNAs flank-
ing large regions (up to 40kb) by excluding low-efficiency
guides. The mode filters all sgRNAs with predicted self-
complementarity, as this can have inhibitory effects on
global Cas9 activity (8,28 and ONT personal communica-
tion); (ii) Knock-in mode. This identifies the same sgRNAs
as the knockout mode, but designs homology arms up to 2
kb, which, based on recent studies (1–3) can be used for tar-
geted insertions; (iii) Activation/repression modes. These
modes are designed for use with Cas9 fusion proteins with
the intention of activating or repressing a gene. Specifically,
the modes target the promoter region and its flanking sites
according to the guidelines specified in (29–31) in order to
bring the activating/repressing domain into close proximity
with the transcription start site.
For the Cas9 knockout mode, we now create a predic-
tion of DSB repair outcomes (24). The model estimates the
probability that a given sgRNA will result in a frameshift
mutation. In addition, we have added efficiency scores
for Cas12a/Cpf1 (21) and updated the ‘Doench’ efficiency
score to the newest version (15), which is now the default
scoring metric for Cas9 genomic targeting.
Expansion of genomes and targeting
CHOPCHOP now supports over 200 genomes and includes
gene annotations for genomic targets, as well as three tran-
scriptomes for RNA knockdown (human, mouse and ze-
brafish). While previous versions of CHOPCHOP required
the selection of a specific isoform for targeting, this new ver-
sion allows the user to target the entire gene. In its default
‘intersection’ mode, CHOPCHOP v3 only searches for sgR-
NAs present in every isoform (Figure 1). This mode can be
disabled by selecting the ‘union’ mode, which will display
all sgRNAs in all transcripts, as well as a column indicating
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Figure 1. The workflow of CHOPCHOP when targeting RNA for knock-down. The CHOPCHOP homepage (upper box) require four types of input: (i)
target, (ii) species, (iii) CRISPR effector and (iv) the purpose of the experiment. Default options will be adequate for most users, but advanced options
can be revealed using the ‘Options’ button. The results of the search (lower box) are displayed along with all isoforms of the target gene. The target color
indicates the quality of each sgRNA or nickase pair (green [best] to red [worst]). Below the graphic representation an interactive table allows for exploring
each guide in greater detail.
Command-line version
In addition to the web interface, we also provide the code
for the command-line version of CHOPCHOP, which can
be run locally and is suited for larger queries or screens.
This tool includes all of the functionality of the web in-
terface in addition to extra functionality for larger exper-
iments, such as the ability to design control sgRNAs that
do not match any sequence in the genome. The command-
line version of CHOPCHOP is compatible with ampliCan,
a tool for sequencing-based assessment of mutations (32).
DISCUSSION AND FUTURE DEVELOPMENTS
Since its inception, the CRISPR field has undergone con-
stant and rapid innovation, requiring the parallel devel-
opment of bioinformatic tools that accommodate the new
findings and technologies. In just a few years, CRISPR–Cas
has become a powerful targeting tool for silencing and ac-
tivating both DNA and RNA in a range of contexts, each
of which requires the application of specific rules. The latest
release of CHOPCHOP addresses this challenge by adding
new functionalities that reflect the ever-expanding CRISPR
toolbox. So far, we have accommodated the favorite species
of over 200 research groups, and as we continue to improve
the functionality of CHOPCHOP, we will continue to ac-
commodate new transcriptomes and genomes.
In conclusion, this major update expands the CHOP-
CHOP toolbox, retaining its position as one of the most
easy-to-use, versatile CRISPR–Cas targeting tools avail-
able.
DATA AVAILABILITY
The CHOPCHOP (version 3) server is available at https://
chopchop.cbu.uib.no; the python code for local installation
is available at https://bitbucket.org/valenlab/chopchop.
ACKNOWLEDGEMENTS
We would like to thank James Graham from Oxford










niversitetsbiblioteket i Bergen user on 07 January 2020
W174 Nucleic Acids Research, 2019, Vol. 47, Web Server issue
FUNDING
Bergen Research Foundation (to E.V.); University of Bergen
core funding (to K.L.); Norwegian Research Council
[250049 to E.V.]; National Defense Science and Engineer-
ing Graduate (NDSEG) Fellowship (to T.G.M.). Funding
for open access charge: Bergens Forskningsstiftelse (Bergen
Research Foundation).
Conflict of interest statement. None declared.
REFERENCES
1. Nakamae,K., Nishimura,Y., Takenaga,M., Nakade,S., Sakamoto,N.,
Ide,H., Sakuma,T. and Yamamoto,T. (2017) Establishment of
expanded and streamlined pipeline of PITCh knock-in - a web-based
design tool for MMEJ-mediated gene knock-in, PITCh designer, and
the variations of PITCh, PITCh-TG and PITCh-KIKO.
Bioengineered, 8, 302–308.
2. Sakuma,T., Nakade,S., Sakane,Y., Suzuki,K.-I.T. and Yamamoto,T.
(2016) MMEJ-assisted gene knock-in using TALENs and
CRISPR–Cas9 with the PITCh systems. Nat. Protoc., 11, 118–133.
3. Suzuki,K., Tsunekawa,Y., Hernandez-Benitez,R., Wu,J., Zhu,J.,
Kim,E.J., Hatanaka,F., Yamamoto,M., Araoka,T., Li,Z. et al. (2016)
In vivo genome editing via CRISPR/Cas9 mediated
homology-independent targeted integration. Nature, 540, 144–149.
4. Maeder,M.L., Linder,S.J., Cascio,V.M., Fu,Y., Ho,Q.H. and
Joung,J.K. (2013) CRISPR RNA-guided activation of endogenous
human genes. Nat. Methods, 10, 977–979.
5. Perez-Pinera,P., Kocak,D.D., Vockley,C.M., Adler,A.F.,
Kabadi,A.M., Polstein,L.R., Thakore,P.I., Glass,K.A.,
Ousterout,D.G., Leong,K.W. et al. (2013) RNA-guided gene
activation by CRISPR–Cas9-based transcription factors. Nat.
Methods, 10, 973–976.
6. Gilbert,L.A., Larson,M.H., Morsut,L., Liu,Z., Brar,G.A.,
Torres,S.E., Stern-Ginossar,N., Brandman,O., Whitehead,E.H.,
Doudna,J.A. et al. (2013) CRISPR-mediated modular RNA-guided
regulation of transcription in eukaryotes. Cell, 154, 442–451.
7. Gabrieli,T., Sharim,H., Fridman,D., Arbib,N., Michaeli,Y. and
Ebenstein,Y. (2018) Selective nanopore sequencing of human BRCA1
by Cas9-assisted targeting of chromosome segments (CATCH).
Nucleic Acids Res., 46, e87.
8. Gilpatrick,T., Lee,I., Graham,J.E., Raimondeau,E., Bowen,R.,
Heron,A., Sedlazeck,F.J. and Timp,W. (2019) Targeted Nanopore
Sequencing with Cas9 for studies of methylation, structural variants
and mutations. bioRxiv doi: https://doi.org/10.1101/604173, 11 April
2019, preprint: not peer reviewed.
9. Halperin,S.O., Tou,C.J., Wong,E.B., Modavi,C., Schaffer,D.V. and
Dueber,J.E. (2018) CRISPR-guided DNA polymerases enable
diversification of all nucleotides in a tunable window. Nature, 560,
248–252.
10. Gootenberg,J.S., Abudayyeh,O.O., Lee,J.W., Essletzbichler,P.,
Dy,A.J., Joung,J., Verdine,V., Donghia,N., Daringer,N.M.,
Freije,C.A. et al. (2017) Nucleic acid detection with
CRISPR–Cas13a/C2c2. Science, 356, 438–442.
11. McKenna,A., Findlay,G.M., Gagnon,J.A., Horwitz,M.S., Schier,A.F.
and Shendure,J. (2016) Whole-organism lineage tracing by
combinatorial and cumulative genome editing. Science, 353, aaf7907.
12. Abudayyeh,O.O., Gootenberg,J.S., Konermann,S., Joung,J.,
Slaymaker,I.M., Cox,D.B.T., Shmakov,S., Makarova,K.S.,
Semenova,E., Minakhin,L. et al. (2016) C2c2 is a single-component
programmable RNA-guided RNA-targeting CRISPR effector.
Science, 353, aaf5573.
13. Cox,D.B.T., Gootenberg,J.S., Abudayyeh,O.O., Franklin,B.,
Kellner,M.J., Joung,J. and Zhang,F. (2017) RNA editing with
CRISPR–Cas13. Science, 358, 1019–1027.
14. Abudayyeh,O.O., Gootenberg,J.S., Essletzbichler,P., Han,S., Joung,J.,
Belanto,J.J., Verdine,V., Cox,D.B.T., Kellner,M.J., Regev,A. et al.
(2017) RNA targeting with CRISPR–Cas13. Nature, 550, 280–284.
15. Doench,J.G., Fusi,N., Sullender,M., Hegde,M., Vaimberg,E.W.,
Donovan,K.F., Smith,I., Tothova,Z., Wilen,C., Orchard,R. et al.
(2016) Optimized sgRNA design to maximize activity and minimize
off-target effects of CRISPR–Cas9. Nat. Biotechnol., 34, 184–191.
16. Chari,R., Mali,P., Moosburner,M. and Church,G.M. (2015)
Unraveling CRISPR–Cas9 genome engineering parameters via a
library-on-library approach. Nat. Methods, 12, 823–826.
17. Xu,H., Xiao,T., Chen,C.-H., Li,W., Meyer,C.A., Wu,Q., Wu,D.,
Cong,L., Zhang,F., Liu,J.S. et al. (2015) Sequence determinants of
improved CRISPR sgRNA design. Genome Res., 25, 1147–1157.
18. Moreno-Mateos,M.A., Vejnar,C.E., Beaudoin,J.-D., Fernandez,J.P.,
Mis,E.K., Khokha,M.K. and Giraldez,A.J. (2015) CRISPRscan:
designing highly efficient sgRNAs for CRISPR–Cas9 targeting in
vivo. Nat. Methods, 12, 982–988.
19. Hsu,P.D., Scott,D.A., Weinstein,J.A., Ran,F.A., Konermann,S.,
Agarwala,V., Li,Y., Fine,E.J., Wu,X., Shalem,O. et al. (2013) DNA
targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol.,
31, 827–832.
20. Cong,L., Ran,F.A., Cox,D., Lin,S., Barretto,R., Habib,N., Hsu,P.D.,
Wu,X., Jiang,W., Marraffini,L.A. et al. (2013) Multiplex genome
engineering using CRISPR/Cas systems. Science, 339, 819–823.
21. Kim,H.K., Min,S., Song,M., Jung,S., Choi,J.W., Kim,Y., Lee,S.,
Yoon,S. and Kim,H.H. (2018) Deep learning improves prediction of
CRISPR–Cpf1 guide RNA activity. Nat. Biotechnol., 36, 239–241.
22. El-Brolosy,M., Rossi,A., Kontarakis,Z., Kuenne,C., Guenther,S.,
Fukuda,N., Takacs,C., Lai,S.-L., Fukuda,R., Gerri,C. et al. (2019)
Genetic compensation is triggered by mutant mRNA degradation.
Nature , 568, 193–197.
23. Gagnon,J.A., Valen,E., Thyme,S.B., Huang,P., Akhmetova,L.,
Ahkmetova,L., Pauli,A., Montague,T.G., Zimmerman,S., Richter,C.
et al. (2014) Efficient mutagenesis by Cas9 protein-mediated
oligonucleotide insertion and large-scale assessment of single-guide
RNAs. PLoS One, 9, e98186.
24. Shen,M.W., Arbab,M., Hsu,J.Y., Worstell,D., Culbertson,S.J.,
Krabbe,O., Cassa,C.A., Liu,D.R., Gifford,D.K. and Sherwood,R.I.
(2018) Predictable and precise template-free CRISPR editing of
pathogenic variants. Nature, 563, 646–651.
25. Konermann,S., Lotfy,P., Brideau,N.J., Oki,J., Shokhirev,M.N. and
Hsu,P.D. (2018) Transcriptome engineering with RNA-targeting type
VI-D CRISPR effectors. Cell, 173, 665–676.
26. Smargon,A.A., Cox,D.B.T., Pyzocha,N.K., Zheng,K.,
Slaymaker,I.M., Gootenberg,J.S., Abudayyeh,O.A., Essletzbichler,P.,
Shmakov,S., Makarova,K.S. et al. (2017) Cas13b is a type VI-B
CRISPR-associated RNA-guided RNase differentially regulated by
accessory proteins Csx27 and Csx28. Mol. Cell, 65, 618–630.
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